Cost analysis of whole genome sequencing in German clinical practice

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Marika Plöthner
  • Martin Frank
  • J. Matthias Graf von der Schulenburg
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)623-633
Seitenumfang11
FachzeitschriftEuropean Journal of Health Economics
Jahrgang18
Ausgabenummer5
Frühes Online-Datum5 Juli 2016
PublikationsstatusVeröffentlicht - Juni 2017

Abstract

Objectives: Whole genome sequencing (WGS) is an emerging tool in clinical diagnostics. However, little has been said about its procedure costs, owing to a dearth of related cost studies. This study helps fill this research gap by analyzing the execution costs of WGS within the setting of German clinical practice. Methodology: First, to estimate costs, a sequencing process related to clinical practice was undertaken. Once relevant resources were identified, a quantification and monetary evaluation was conducted using data and information from expert interviews with clinical geneticists, and personnel at private enterprises and hospitals. This study focuses on identifying the costs associated with the standard sequencing process, and the procedure costs for a single WGS were analyzed on the basis of two sequencing platforms—namely, HiSeq 2500 and HiSeq Xten, both by Illumina, Inc. In addition, sensitivity analyses were performed to assess the influence of various uses of sequencing platforms and various coverage values on a fixed-cost degression. Results: In the base case scenario—which features 80 % utilization and 30-times coverage—the cost of a single WGS analysis with the HiSeq 2500 was estimated at €3858.06. The cost of sequencing materials was estimated at €2848.08; related personnel costs of €396.94 and acquisition/maintenance costs (€607.39) were also found. In comparison, the cost of sequencing that uses the latest technology (i.e., HiSeq Xten) was approximately 63 % cheaper, at €1411.20. Conclusions: The estimated costs of WGS currently exceed the prediction of a ‘US$1000 per genome’, by more than a factor of 3.8. In particular, the material costs in themselves exceed this predicted cost.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Cost analysis of whole genome sequencing in German clinical practice. / Plöthner, Marika; Frank, Martin; von der Schulenburg, J. Matthias Graf.
in: European Journal of Health Economics, Jahrgang 18, Nr. 5, 06.2017, S. 623-633.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Plöthner M, Frank M, von der Schulenburg JMG. Cost analysis of whole genome sequencing in German clinical practice. European Journal of Health Economics. 2017 Jun;18(5):623-633. Epub 2016 Jul 5. doi: 10.1007/s10198-016-0815-0
Plöthner, Marika ; Frank, Martin ; von der Schulenburg, J. Matthias Graf. / Cost analysis of whole genome sequencing in German clinical practice. in: European Journal of Health Economics. 2017 ; Jahrgang 18, Nr. 5. S. 623-633.
Download
@article{ed01c2cac0104b3e8ba20d72b47112ba,
title = "Cost analysis of whole genome sequencing in German clinical practice",
abstract = "Objectives: Whole genome sequencing (WGS) is an emerging tool in clinical diagnostics. However, little has been said about its procedure costs, owing to a dearth of related cost studies. This study helps fill this research gap by analyzing the execution costs of WGS within the setting of German clinical practice. Methodology: First, to estimate costs, a sequencing process related to clinical practice was undertaken. Once relevant resources were identified, a quantification and monetary evaluation was conducted using data and information from expert interviews with clinical geneticists, and personnel at private enterprises and hospitals. This study focuses on identifying the costs associated with the standard sequencing process, and the procedure costs for a single WGS were analyzed on the basis of two sequencing platforms—namely, HiSeq 2500 and HiSeq Xten, both by Illumina, Inc. In addition, sensitivity analyses were performed to assess the influence of various uses of sequencing platforms and various coverage values on a fixed-cost degression. Results: In the base case scenario—which features 80 % utilization and 30-times coverage—the cost of a single WGS analysis with the HiSeq 2500 was estimated at €3858.06. The cost of sequencing materials was estimated at €2848.08; related personnel costs of €396.94 and acquisition/maintenance costs (€607.39) were also found. In comparison, the cost of sequencing that uses the latest technology (i.e., HiSeq Xten) was approximately 63 % cheaper, at €1411.20. Conclusions: The estimated costs of WGS currently exceed the prediction of a {\textquoteleft}US$1000 per genome{\textquoteright}, by more than a factor of 3.8. In particular, the material costs in themselves exceed this predicted cost.",
keywords = "Cost analysis, German clinical practice, Whole genome sequencing",
author = "Marika Pl{\"o}thner and Martin Frank and {von der Schulenburg}, {J. Matthias Graf}",
note = "Publisher Copyright: {\textcopyright} 2016, Springer-Verlag Berlin Heidelberg. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2017",
month = jun,
doi = "10.1007/s10198-016-0815-0",
language = "English",
volume = "18",
pages = "623--633",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "5",

}

Download

TY - JOUR

T1 - Cost analysis of whole genome sequencing in German clinical practice

AU - Plöthner, Marika

AU - Frank, Martin

AU - von der Schulenburg, J. Matthias Graf

N1 - Publisher Copyright: © 2016, Springer-Verlag Berlin Heidelberg. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.

PY - 2017/6

Y1 - 2017/6

N2 - Objectives: Whole genome sequencing (WGS) is an emerging tool in clinical diagnostics. However, little has been said about its procedure costs, owing to a dearth of related cost studies. This study helps fill this research gap by analyzing the execution costs of WGS within the setting of German clinical practice. Methodology: First, to estimate costs, a sequencing process related to clinical practice was undertaken. Once relevant resources were identified, a quantification and monetary evaluation was conducted using data and information from expert interviews with clinical geneticists, and personnel at private enterprises and hospitals. This study focuses on identifying the costs associated with the standard sequencing process, and the procedure costs for a single WGS were analyzed on the basis of two sequencing platforms—namely, HiSeq 2500 and HiSeq Xten, both by Illumina, Inc. In addition, sensitivity analyses were performed to assess the influence of various uses of sequencing platforms and various coverage values on a fixed-cost degression. Results: In the base case scenario—which features 80 % utilization and 30-times coverage—the cost of a single WGS analysis with the HiSeq 2500 was estimated at €3858.06. The cost of sequencing materials was estimated at €2848.08; related personnel costs of €396.94 and acquisition/maintenance costs (€607.39) were also found. In comparison, the cost of sequencing that uses the latest technology (i.e., HiSeq Xten) was approximately 63 % cheaper, at €1411.20. Conclusions: The estimated costs of WGS currently exceed the prediction of a ‘US$1000 per genome’, by more than a factor of 3.8. In particular, the material costs in themselves exceed this predicted cost.

AB - Objectives: Whole genome sequencing (WGS) is an emerging tool in clinical diagnostics. However, little has been said about its procedure costs, owing to a dearth of related cost studies. This study helps fill this research gap by analyzing the execution costs of WGS within the setting of German clinical practice. Methodology: First, to estimate costs, a sequencing process related to clinical practice was undertaken. Once relevant resources were identified, a quantification and monetary evaluation was conducted using data and information from expert interviews with clinical geneticists, and personnel at private enterprises and hospitals. This study focuses on identifying the costs associated with the standard sequencing process, and the procedure costs for a single WGS were analyzed on the basis of two sequencing platforms—namely, HiSeq 2500 and HiSeq Xten, both by Illumina, Inc. In addition, sensitivity analyses were performed to assess the influence of various uses of sequencing platforms and various coverage values on a fixed-cost degression. Results: In the base case scenario—which features 80 % utilization and 30-times coverage—the cost of a single WGS analysis with the HiSeq 2500 was estimated at €3858.06. The cost of sequencing materials was estimated at €2848.08; related personnel costs of €396.94 and acquisition/maintenance costs (€607.39) were also found. In comparison, the cost of sequencing that uses the latest technology (i.e., HiSeq Xten) was approximately 63 % cheaper, at €1411.20. Conclusions: The estimated costs of WGS currently exceed the prediction of a ‘US$1000 per genome’, by more than a factor of 3.8. In particular, the material costs in themselves exceed this predicted cost.

KW - Cost analysis

KW - German clinical practice

KW - Whole genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84977156766&partnerID=8YFLogxK

U2 - 10.1007/s10198-016-0815-0

DO - 10.1007/s10198-016-0815-0

M3 - Article

C2 - 27380512

AN - SCOPUS:84977156766

VL - 18

SP - 623

EP - 633

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 5

ER -